{"pmid":32468166,"title":"Acute kidney injury associated with COVID-19: another extrapulmonary manifestation.","text":["Acute kidney injury associated with COVID-19: another extrapulmonary manifestation.","Int Urol Nephrol","Barros Camargo, Luis","Quintero Marzola, Ivan Dario","Cardenas Gomez, Juan Carlos","Mendoza Daza, Leidy Tatiana","Quintana Pajaro, Loraine","32468166"],"journal":"Int Urol Nephrol","authors":["Barros Camargo, Luis","Quintero Marzola, Ivan Dario","Cardenas Gomez, Juan Carlos","Mendoza Daza, Leidy Tatiana","Quintana Pajaro, Loraine"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468166","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s11255-020-02507-w","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668167109987794944,"score":9.490897,"similar":[{"pmid":32425338,"pmcid":"PMC7233216","title":"Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.","text":["Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.","COVID-19 is principally a respiratory illness and pulmonary manifestations constitute main presentations of the disease. According to the reported studies, SARS-CoV-2 infection is not limited to the respiratory system and other organs can be also affected. Renal dysfunction, gastrointestinal complications, liver dysfunction, cardiac manifestations, mediastinal findings, neurological abnormalities, and hematological manifestations are among the reported extrapulmonary features. Considering the broad spectrum of clinical manifestations and the increasing worldwide burden of the disease, there is an urgent need to rapidly scale up the diagnostic capacity to detect COVID-19 and its complications. This paper focuses on the most common extrapulmonary manifestations in patients with COVID-19 pneumonia. Further studies are needed to elaborate and confirm the causative relationship between SARS-CoV-2 and the reported extrapulmonary manifestations of COVID-19.","Clin Imaging","Behzad, Shima","Aghaghazvini, Leila","Radmard, Amir Reza","Gholamrezanezhad, Ali","32425338"],"abstract":["COVID-19 is principally a respiratory illness and pulmonary manifestations constitute main presentations of the disease. According to the reported studies, SARS-CoV-2 infection is not limited to the respiratory system and other organs can be also affected. Renal dysfunction, gastrointestinal complications, liver dysfunction, cardiac manifestations, mediastinal findings, neurological abnormalities, and hematological manifestations are among the reported extrapulmonary features. Considering the broad spectrum of clinical manifestations and the increasing worldwide burden of the disease, there is an urgent need to rapidly scale up the diagnostic capacity to detect COVID-19 and its complications. This paper focuses on the most common extrapulmonary manifestations in patients with COVID-19 pneumonia. Further studies are needed to elaborate and confirm the causative relationship between SARS-CoV-2 and the reported extrapulmonary manifestations of COVID-19."],"journal":"Clin Imaging","authors":["Behzad, Shima","Aghaghazvini, Leila","Radmard, Amir Reza","Gholamrezanezhad, Ali"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425338","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.clinimag.2020.05.013","keywords":["covid-19","extrapulmonary manifestation","gastrointestinal complications","liver dysfunction","lymphadenopathy","neurological manifestations","pericardial effusion","renal dysfunction","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1667352728680005632,"score":51.92237},{"pmid":32252978,"pmcid":"PMC7195310","title":"Suspected acute abdomen as an extrapulmonary manifestation of Covid-19 infection.","text":["Suspected acute abdomen as an extrapulmonary manifestation of Covid-19 infection.","Cir Esp","Blanco-Colino, Ruth","Vilallonga, Ramon","Martin, Rocio","Petrola, Carlos","Armengol, Manuel","32252978"],"journal":"Cir Esp","authors":["Blanco-Colino, Ruth","Vilallonga, Ramon","Martin, Rocio","Petrola, Carlos","Armengol, Manuel"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32252978","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ciresp.2020.03.006","weight":0,"_version_":1666138493153181696,"score":48.246696},{"pmid":32416116,"title":"ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19.","text":["ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19.","The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted with Covid-19, AKI developed in 1,993 (36.6%). The peak stages of AKI were stage 1 in 46.5%, stage 2 in 22.4% and stage 3 in 31.1%. Of these, 14.3% required renal replacement therapy (RRT). AKI was primarily seen in Covid-19 patients with respiratory failure, with 89.7% of patients on mechanical ventilation developing AKI compared to 21.7% of non-ventilated patients. 276/285 (96.8%) of patients requiring RRT were on ventilators. Of patients who required ventilation and developed AKI, 52.2% had the onset of AKI within 24 hours of intubation. Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Among patients with AKI, 694 died (35%), 519 (26%) were discharged and 780 (39%) were still hospitalized. AKI occurs frequently among patients with Covid-19 disease. It occurs early and in temporal association with respiratory failure and is associated with a poor prognosis.","Kidney Int","Hirsch, Jamie S","Ng, Jia H","Ross, Daniel W","Sharma, Purva","Shah, Hitesh H","Barnett, Richard L","Hazzan, Azzour D","Fishbane, Steven","Jhaveri, Kenar D","32416116"],"abstract":["The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted with Covid-19, AKI developed in 1,993 (36.6%). The peak stages of AKI were stage 1 in 46.5%, stage 2 in 22.4% and stage 3 in 31.1%. Of these, 14.3% required renal replacement therapy (RRT). AKI was primarily seen in Covid-19 patients with respiratory failure, with 89.7% of patients on mechanical ventilation developing AKI compared to 21.7% of non-ventilated patients. 276/285 (96.8%) of patients requiring RRT were on ventilators. Of patients who required ventilation and developed AKI, 52.2% had the onset of AKI within 24 hours of intubation. Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Among patients with AKI, 694 died (35%), 519 (26%) were discharged and 780 (39%) were still hospitalized. AKI occurs frequently among patients with Covid-19 disease. It occurs early and in temporal association with respiratory failure and is associated with a poor prognosis."],"journal":"Kidney Int","authors":["Hirsch, Jamie S","Ng, Jia H","Ross, Daniel W","Sharma, Purva","Shah, Hitesh H","Barnett, Richard L","Hazzan, Azzour D","Fishbane, Steven","Jhaveri, Kenar D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416116","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.kint.2020.05.006","keywords":["aki","covid-19","crrt","dialysis","renal failure"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666994545963827200,"score":45.905598},{"pmid":32362365,"pmcid":"PMC7174190","title":"About the scientific letter 'Suspected acute abdomen as an extrapulmonary manifestation of COVID-19 infection'.","text":["About the scientific letter 'Suspected acute abdomen as an extrapulmonary manifestation of COVID-19 infection'.","Cir Esp","Pardo Aranda, Fernando","32362365"],"journal":"Cir Esp","authors":["Pardo Aranda, Fernando"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362365","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ciresp.2020.04.015","weight":0,"_version_":1666138496026279937,"score":45.883457},{"pmid":32145717,"title":"[Diagnosis and treatment of COVID-19: acute kidney injury cannot be ignored].","text":["[Diagnosis and treatment of COVID-19: acute kidney injury cannot be ignored].","Zhonghua Yi Xue Za Zhi","Yang, X H","Sun, R H","Chen, D C","32145717"],"journal":"Zhonghua Yi Xue Za Zhi","authors":["Yang, X H","Sun, R H","Chen, D C"],"date":"2020-03-09T11:00:00Z","year":2020,"_id":"32145717","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.3760/cma.j.cn112137-20200229-00520","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138492743188480,"score":44.24434}]}